Default company panoramic image
29dea9ee 789a 42b5 8ed4 943663467336

XL-protein GmbH

XL-protein seeks € 12 VC funding (Ser.A) for its spin-out XL-biologics to develop a PASylated CD40L-Fab until the end of clinical phase I.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Freising, BY, Deutschland
  • Currency EUR
  • Founded May 2009
  • Employees 8
  • Website

Company Summary

XL-protein, a privately owned German biopharmaceutical company, develops superior biopharmaceuticals with extended plasma half-life utilising the revolutionary PASylation® technology. XL-protein’s goal is to provide improved second generation biologics that permit less frequent and lower dosing together with better tolerability, thus making treatment cheaper and supporting patients compliance and safety.


  • Default avatar
    Prof. Dr. Arne Skerra

    Arne Skerra is Full Professor at the Technische Universität München, where he heads the Institute of Biological Chemistry since 1998. He holds a Diploma degree in chemistry from the Technische Universität Darmstadt and a PhD in Biochemistry from the Ludwig-Maximilians-Universität München. After post-doctoral studies at the MRC Laboratory of Molecular Biology in Cambridge, UK, and a group leader position at the Max-Planck-Institute for Biophysics

  • Default avatar
    Claus Schalper

    Claus Schalper has a solid background in financial management, combined with practical experience in fund raising and driving business growth. Mr. Schalper began his career with Arthur Andersen in the Audit and Corporate Finance Department. Subsequently, he joined a start-up company in the area of healthcare IT software as general partner. Following the trade-sale of the company, Mr. Schalper served as an advisor to venture capitalists specializi

  • Default avatar
    Uli Binder

    Uli Binder studied protein biochemistry, microbiology, and also business administration and he received his Master's degree in molecular biotechnology from the Technische Universität München in 2006. He worked on his PhD thesis in the field of protein engineering in the laboratory of Prof. Skerra. He participated in setting up the Gene Technology Visitors' Lab at the Deutsche Museum München and acted for several years as course instructor for var